Antiphospholipid Antibodies – a tool for the screening of repeated spontaneous abortion

Zafar Iqbal, Tasneem Zafar, Waqas Zafar, Tooba Zafar, Sana Waqas


DOI: http://dx.doi.org/10.22200/pjpr.2017118-23

Abstract


Objective:-

To evaluate the biomedical and clinical significance of antiphospholipid antibodies in women with repeated spontaneous abortion.

Place & Duration:-

Mohi-u-Din Islamci Medical College & DHQ Hospital, Mirpur, AJ & K, from March to December 2013.

Methodology:-

50 subjects with history of three spontaneous abortions in their first trimester of pregnancy were included in this study & fifty women of corresponding age, with one, more alive babies having no record of any first three months spontaneous abortion were taken as controls. Coagulation tests, platelet count, prothrombin time and activated partial thromboplastin time were done by standards methods. Antiphospholipid Antibodies were estimated by ELISA method using specific kits.

Results:-

Mean serum Antiphospholipid Antibodies level was 7.10+3.47 in patients and 6.30+2.02 in controls. The difference in serum level of two groups was significant. Mean platelet count, mean prothrombin time & activated partial thromboplastin time revealed no significant difference between patients and controls.

Conclusion:-

It is concluded that there is a strong association of antiphospholipid antibodies in the patients having recurrent spontaneous abortions so there is a strong need of including this test in the primary screening of such disease in the pregnant women who have history of previous repeated spontaneous abortion. 


Keywords


Antiphospholipid antibodies, abortion, prothrombin time, activated partial thromboplastin time.

Full Text:

PDF

References


Nielsen HS, Christiansen OB. Prognostic impact of Anticardiolipin antibodies in women iwth recurrent miscarriage negative for lupus anticoagulant Human Reproduction 2005:20(6).1720-8

Kalra S, Tuli A, Goyal U, choudhary R, Raheja S. Correlation of Anticardiolipin Antibody IgM with first Trimester Recurrent Abortions. J Anat.Soc.India 2010:51(1);10-23.

Dasgupta S. Immunologically complicated pregnancy. In: Pregnancy at risk: Current concepts. Krisna u, Tank Dk Daffary S (eds).4th ed: New Dehli, Jaypee Brother, 2001;p194-99.

Petrozza JC, Berlin I. Recurrent early pregnancy loss Medicinespecialities updated: J Anat Soc india. 2010;50(1):37-9.

Meka A, Reddy BM. Recurrent spontaneous abortion; an overview of genetic and non-genetic background. Int J hum Genet 2006;(2):109-17

Dasgupta S. Immunologically complicated pregnancy. In: Pregnancy at risk: Current concepts. Krisna u, Tank Dk Daffary S (eds).4th ed: New Dehli, Jaypee Brother, 2001;p194-99.

Salamat N, Saleem M, Ahmed T. Lupus coagulant and anticordiolipin antibodies in patients with recurrent fetal loss: A case control Study. Ann Saudi Med. 2000;20(5-6):450-3.

SIKARA MP et al: β2 glycoprotein I ( β2GPI) binds platelet factor 4 (PF4): Implications for the pathogenesis of Antiphospholipid syndrome. Blood 115:713,2010

TEKTONIDOU M et al: Risk factros for thrombosis and primary thrombosis prevention in patients with systemic lupus erythromatosus with or without antiphospholipid antibodies. Arthritis Rhem 61:29,2009

Ulandera VM, Stefanovica V, Masudab j, Suzukic k, Hiilesmaaa V, Kaajaa R. Plasma level of annexin 1V and VI in relation to Antiphospholipid antibody status in women with history of recurrent miscarriages. Thrombosis research; 2007:120(6);865-70

American College of Obstericians and Gynecologists. Practice Bulletin no.132: Antiphospholipid Syndrome. Obstet Gynecol.2012 Dec,120(6):1514-21.(PMID:23168789).

Mohsin S, ilyas A, Dar LR, Rasool G, Hussain MS, Ullah I. Levels of Anti-Phospholipid antibodies in females with Recurrent abortions. Ann Pak Inst Med Sci. 2011;7(3)156-9

SIKARA MP et al: β2 glycoprotein I ( β2GPI) binds platelet factor 4 (PF4): Implications for the pathogenesis of Antiphospholipid syndrome. Blood 115:713,2010

S M Lewis, B J. I Bates. Practical Hematology. 10th Edition. Churchill livingstone. Coagulation disorders, 2010;523-9.

Kirkwood BR,Sterne JAC.Essential medical statistics.2nd ed:Oxford, Blackwell Science 2008;976-9.

Ulandera VM, Stefanovica V, Masudab j, Suzukic k, Hiilesmaaa V, Kaajaa R. Plasma level of annexin 1V and VI in relation to Antiphospholipid antibody status in women with history of recurrent miscarriages. Thrombosis research; 2007:120(6);865-7

CEVERA R et al: Antiphospholipid Syndrom: Clinical & Immunologic manifestations & patterns of disease expresion in a cohort of 1,000 patients. Arthritis Rheum 46:1019,2002

Meka A, Reddy BM. Recurrent spontaneous abortion; an overview of genetic and non-genetic background. Int J hum Genet 2006;(2):109-17

Nielsen HS, Christiansen OB. Prognostic impact of Anticardiolipin antibodies in women iwth recurrent miscarriage negative for lupus anticoagulant Human Reproduction 2005:20(6).1720-8

Ayyub M, Naeem M, Anwar M, Waqar A, Ali W, Hussain T et al. Clinicopathological features of Lupus anticoagulant; experience at AFIP during last seven years. Med Sci Monit 2005;11(11):536-9.

Daugas E, et al. ( 2002 ). Antiphospholipid Syndrome nephropathy in systemic Lupus erythematosus. J Am Sol Nephrol,13,42-52

Ulandera VM, Stefanovica V, Masudab j, Suzukic k, Hiilesmaaa V, Kaajaa R. Plasma level of annexin 1V and VI in relation to Antiphospholipid antibody status in women with history of recurrent miscarriages. Thrombosis research; 2007:120(6);865-70

SIKARA MP et al: β2 glycoprotein I ( β2GPI) binds platelet factor 4 (PF4): Implications for the pathogenesis of Antiphospholipid syndrome. Blood 115:713,2010

MIYAKIS S et al: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).J Thromb Haemost 295:4.2006.

RUIZ-IRASTORZA G et al: Antiphospholipid syndrome. Lancet 376:1498,2010

Branch DW, Silver R, Pierangeli SI, Leeuwen V, Haris EN. Antiphospholipid antibodies other than lupus anticoagulant and antiphospholipid antibodies in women with recurrent loss, fertililty and anti-phospholipid syndrome. Obsted.Gynecol,1997:89 (4):549-55.

Lockwood C.J, Reece RA, Romero R, Hobins, JC Antiphospholipid antibody and pregnancy wastage. Lancet 1986:328 (8509);742-3.

Kalra S, Tuli A, Goyal U, Chaudhary R, Raheja S. Correlation of Anticardiolipin Antibody IgM with first Trimester Recurrent Abortions. J Anat.Soc.India 2013:51(1);10-23.

Khan A, Tayyib M, Tasneem T, Farooq M, Rehman F, Ujjan ID. Serum anticardiolipin antibodies in recurrent abortion. Ann king Edward Med Univ 2004;10(4):406-7.

Mohsin S, ilyas A, Dar LR, Rasool G, Hussain MS, Ullah I. Levels of Anti-Phospholipid antibodies in females with Recurrent abortions. Ann Pak Inst Med Sci. 2011;7(3)156-9

Glasuddin ASM, Mazhar I, Haq AM. Prevalence of anticardiolipin antibody in Bangladeshi patients with recurrent pregnancy loss. Bangladesh Med Res Counc Bull 2010:36;10-13.

Salamat N, Saleem M, Ahmed T. Lupus coagulant and anticordiolipin antibodies in patients with recurrent fetal loss: A case control Study. Ann Saudi Med. 2000;20(5-6):450-3.

VLACHOYIANNOPOULOS PG et al: Antiphospholipid antibodies: Laboratory and pathogenetic aspects. Crit Rev Clin Lab Sci 271:44, 2007.




DOI: http://dx.doi.org/10.22200/pjpr.2017118-23

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Pakistan Journal of Pharmaceutical Research

Copyright © 2014 All Rights Reserved  Pakistan Journal of Pharmaceutical Research 
Powered by Department of Pharmacy BZU | Designed By: Muqeet Wahid